Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer

The standard treatment for metastatic prostate cancer (PCa), androgen deprivation therapy (ADT), is designed to suppress androgen receptor (AR) activity. However, men invariably progress to castration-resistant prostate cancer (CRPC), and AR reactivation contributes to progression in most cases. To...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Res
Главные авторы: Russo, Joshua W., Gao, Ce, Bhasin, Swati S., Voznesensky, Olga S., Calagua, Carla, Arai, Seiji, Nelson, Peter S., Montgomery, Bruce, Mostaghel, Elahe A., Corey, Eva, Taplin, Mary-Ellen, Ye, Huihui, Bhasin, Manoj, Balk, Steven P.
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239953/
https://ncbi.nlm.nih.gov/pubmed/30242112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-0687
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы